vivoPharm expands, TGR contracts
Wednesday, 06 February, 2008
Adelaide-based contract research organisation vivoPharm is to open a European subsidiary in Germany after receiving an injection of venture capital funds.
vivoPharm Europe will be based in Munich and headed by Dr Katja Wosikowski. It aims to develop new business and maintain relationships with existing customers in Austria, Germany, Switzerland, Spain and Norway.
vivoPharm was established in 2003 and offers integrated preclinical services to the biotechnology and pharmaceutical industries.
It received $1 million in venture capital from the South Australian Life Sciences Advancement Fund, managed by Terra Rossa Capital.
Another Adelaide biotech, TGR BioSciences, has appointed former PricewaterhouseCoopers (PwC) life sciences specialist Andrew Sneddon to its board.
TGR specialises in drug discovery for oral and gastrointestinal health and skin and tissue repair.
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
